PEP/NEWS — Peptide intel. Daily.

Try TrueDark glasses: https://truedark.com Try Danger Coffee: https://dangercoffee.com/discount/davetube Try Suppgrade Labs: https://shopsuppgradelabs.com/ This video explains the most effective ways to lose visceral fat, escalating from l

EP. 276: Join my NEW menopause community for women: https://www.skool.com/drtyna In this episode, I'm talking with plastic surgeon Dr. Anthony Youn about what to know before getting cosmetic procedures and how to approach aging from the in

Bryan Johnson's team breaks down why most consumer hair-loss devices use LEDs while marketing themselves as laser therapy. LLLT (low-level laser light therapy) is the evidence-backed option, with hair regrowth seen in 16-week studies.

The gut microbiome links to immune function, brain health, and metabolic rate. This overview covers pre-, pro-, and postbiotic research and what each does in the aging gut.

Kate Tolo used multispectral imaging of 8 skin markers to track her skin age reversal. She shares the full intervention stack, measured objectively over multiple years.

NMR blood analysis can flag cardiovascular risk, insulin resistance (HOMA-IR), inflammation, and mortality risk in one scan. Jim Otvos walks through what that means for longevity medicine.

Senescent cells accumulate in aging lung tissue and drive chronic inflammation. Animal studies show senolytic therapies can slow or reverse this process in conditions like idiopathic pulmonary fibrosis.

Without accurate biological age measurement, it's hard to know which therapies — including peptides — actually move the needle. This piece reviews where the field stands and what's needed.

A Nature Aging study found that physical activity delays ovarian aging partly through adiponectin-linked pathways. The work maps a new hormonal mechanism between muscle activity and reproductive longevity.

Researchers found that GATA4 (a gene regulator) rises in aging joint cartilage cells. Higher GATA4 levels track with reduced repair capacity and the start of osteoarthritis — a potential new target for recovery peptide research.

Attia unpacks the design limits of multifactorial trials — the kind often used to study peptide stacks and longevity protocols. Understanding what these studies can prove changes how you read the data.